Friday, 4 March 2016

International Conference on Epilepsy & Treatment

About Conference


OMICS International Conference Series provides the perfect platform for global networking and our Epilepsy Conference 2016 aims to gather the Professors, Researchers, Business Delegates, Scientists, students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences. 
We are truly delighted to invite you to attend the 2nd International Conference on Epilepsy and Treatment, during October 20-21, 2016 at Rome, ItalyEpilepsy global summit will provide two days of robust discussions for the treatment of various types of Epilepsy and its effects in pregnant women, Infantile Seizures, Genetic causes, mutations and other novel diagnostic and therapeutic strategies of Epilepsy. It will also explore new ideas and concepts on a global scale.
Theme: “Explore and Disseminate Knowledge of Epilepsy Research and its Novel Therapeutic Approaches
Epilepsy is a chronic brain disorder. More than 50 million people were affected worldwide. Synchronous brain cell activity causes seizures and depending on the region of brain affected they will produce a range of behaviors. It is estimated that every year nearly 2.4 million people are diagnosed with epilepsy and the population with active epilepsy is between 4 to10 per 1000 people. Nearly 80% of the individuals with epilepsy are found in developing regions. Historically, the epilepsy research has been under-funded.  Annually NIH spends $30 billion for medical research, but ½ of 1% is only spent on Epilepsy research. Of total medical costs Epilepsy alone results in an estimated annual cost of $15.5 billion.
Our  Epileptic brain conference is assured to act as a catalyst for the advancement in Epilepsy by connecting adepts within and across disciplines under a single roof of knowledge, creating an environment conducive to information exchange, generation of new ideas and acceleration of applications to benefit the nascent research and society.
Importance and Scope:
Epilepsy is a chronic disorder of the brain that affects people of all ages. According to WHO (World Health Organization) statistics more than 50 million people were affected worldwide. It is estimated that every year nearly 2.4 million people are diagnosed with epilepsy and the population with active epilepsy is between 4 to10 per 1000 people. Nearly 80% of the individuals with epilepsy are found in developing regions. Approximately 500,000 Italians suffer from epilepsy, of which 125,000 have treatment resistant forms. Historically, the epilepsy research has been under-funded. 
Annually NIH spends $30 billion for medical research, but ½ of 1% is only spent on epilepsy research. Of total medical costs Epilepsy alone results in an estimated annual cost of $15.5 billion. In developing countries, this figure is often close to twice as high due to the higher risk of experiencing conditions which leads to permanentbrain damage. The risk of premature death in people with epilepsy is two to three times higher than it is for the general population.
Target Audience:
Neurologists, Epileptologists, Pharmacists, Research scientists, Epilepsy organizations, Pharmaceutical (drug design and discovery) companies, Anti- Epileptic drug Industries, Epilepsy associations & foundations, Professors and Students from Academia interested in the study of Epilepsy.

Conference Highlights


  • Epilepsy
  • Neurobiology and Pathophysiology of Epilepsy
  • Causes of Epilepsy
  • Epilepsy Therapeutics
  • Epilepsy in Women and Inborn
  • Major types of Epilepsies
  • Epileptic Syndromes
  • Advanced Epilepsy Diagnosis Tests
  • Prevention and Management of Epilepsy
  • Impact of the Epilepsies on daily life
  • Diseases Associated with Epilepsy
  • Epilepsy Imitators
  • Epilepsy Case Reports

Special Issues


  •  All accepted abstracts will be published in respective OMICS   International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.